A Predictive Model for Early Metastasis in Cervical Cancer Patients After Radiotherapy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age20-85
SponsorFujian Cancer Hospital
About this trial
This study aims to help to screen out appropriate cases for consolidation therapy and more intensive follow up.
Eligibility criteria
Qualifiers
patients confirmed as cervical cancer by biopsies and treated with radiotherapy were initially enrolled
Disqualifiers
(1) patients treated with surgery. (2) patient received incomplete treatment somewhere else. (3) patients with cancer history. (4) patients with pelvic surgery history. (5) patients without complete pre-treatment medical information. (6) patients with unfinished radical radiotherapy. (7) patients suffered from metastasis within 3 months after radiotherapy. (8) patients without complete 1-year follow-up materials
Trial design
Treatments tested in this trial
- external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)
Treatment groups
500 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov